Becton, Dickinson and Company Stock: Analyst Estimates & Ratings
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 16 2025
0mins
Source: NASDAQ.COM
Company Overview and Performance: Becton, Dickinson and Company (BDX), a global medical technology firm, has seen its shares drop 27.4% over the past year, underperforming the S&P 500 and the SPDR S&P Health Care Equipment ETF. Despite a revenue increase in Q2 2025, mixed results led to an 18.1% decline in share price following earnings release.
Future Outlook and Analyst Ratings: BDX raised its fiscal 2025 revenue outlook but lowered adjusted EPS guidance, affecting investor confidence. Analysts maintain a "Moderate Buy" consensus rating, with a revised price target of $196, while the highest target suggests a potential upside of 65.4%.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy BDX?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on BDX
Wall Street analysts forecast BDX stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for BDX is 202.38 USD with a low forecast of 183.00 USD and a high forecast of 220.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
8 Analyst Rating
3 Buy
5 Hold
0 Sell
Moderate Buy
Current: 206.510
Low
183.00
Averages
202.38
High
220.00
Current: 206.510
Low
183.00
Averages
202.38
High
220.00
About BDX
Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring, and pharmaceutical systems. Its BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Becton, Dickinson Q1 Earnings Exceed Expectations
- Earnings Beat: Becton, Dickinson reported a Q1 non-GAAP EPS of $2.91, exceeding expectations by $0.10, reflecting strong performance in the medical device sector and boosting investor confidence.
- Revenue Growth: The company achieved Q1 revenue of $5.25 billion, a 1.5% year-over-year increase, surpassing market expectations by $100 million, indicating stable product demand and solid sales momentum in a competitive market.
- FY26 Guidance Affirmation: Becton, Dickinson affirmed its FY26 revenue growth guidance, projecting GAAP revenue growth in the low single digits, which reflects the company's confidence in future performance while considering corporate overhead migration to Waters Corp.
- Adjusted EPS Outlook: The adjusted diluted EPS guidance is set at $12.35 to $12.65, below the consensus estimate of $14.79, indicating a cautious approach in light of cost control and changing market conditions.
See More
BD Reports Strong Q1 2026 Results and Strategic Milestone
- Strong Performance: BD reported Q1 2026 revenues of $5.252 billion, reflecting a 1.6% year-over-year increase, demonstrating robust growth across key markets and disciplined execution, which positions the company well for future revenue and earnings growth.
- Earnings Growth: The reported diluted earnings per share reached $1.34, up 28.8% from the previous year, indicating successful cost control and operational efficiency, thereby enhancing investor confidence in the company's future performance.
- Strategic Restructuring: BD anticipates completing the merger of its Biosciences and Diagnostic Solutions business with Waters Corporation, marking a significant milestone that will pivot the company towards
See More
U.S. Stock Futures Rise, Focus on Aecom and ON Semiconductor
- Aecom Earnings Forecast: Aecom (NYSE:ACM) is projected to report quarterly earnings of $1.17 per share on revenue of $3.61 billion, indicating stable growth in the infrastructure sector that may enhance investor confidence.
- Stock Performance: Aecom shares rose 2.4% to close at $101.03 on Friday, reflecting optimistic market sentiment ahead of its earnings report, which could attract more investor attention.
- ON Semiconductor Earnings Outlook: Analysts expect ON Semiconductor Corp. (NASDAQ:ON) to post quarterly earnings of 62 cents per share with revenue of $1.54 billion, suggesting ongoing demand and growth potential in the semiconductor market.
- Stock Movement: ON Semiconductor shares gained 0.1% in after-hours trading, closing at $65.23, indicating market anticipation for its earnings report, which may influence future investment decisions.
See More
U.S. Stocks Rally as Dow Hits Record Highs
- Market Sentiment Improvement: The CNN Money Fear & Greed Index rose to 45 on Friday, entering the 'Neutral' zone from a previous reading of 34.2, indicating a significant improvement in market sentiment that could boost investor confidence.
- Dow Jones Surge: The Dow Jones Industrial Average jumped over 1,200 points during Friday's session, closing at 50,115.67 and marking its first breach of the 50,000-point milestone, showcasing a strong market rebound that may attract more capital inflows.
- S&P 500 Strong Performance: The S&P 500 rose by 1.97% to close at 6,932.30, with sectors like industrials, energy, and information technology recording significant gains, reflecting positive signals of economic recovery that could drive corporate earnings growth.
- Consumer Confidence Boost: The University of Michigan's consumer sentiment index increased by 0.9 points to 57.3 in February, surpassing market estimates of 55, indicating enhanced consumer confidence in the economic outlook, which may stimulate consumer spending and economic growth.
See More
Key Focus Areas This Week: Jobs, Consumer Prices, Coca-Cola, CVS, Ford, McDonald's, and More
- Market Performance: The Dow Jones Industrial Average rose by 2.5% and closed above 50,000 for the first time.
- Nasdaq Struggles: In contrast, the Nasdaq Composite ended the week down 1.8%, despite a strong rally on Friday.
See More
U.S. Jobs and Inflation Data Set for Release
- Job Data Expectations: The U.S. is expected to add 60,000 jobs in January, up from 50,000 in December, which could influence the Fed's monetary policy direction amidst ongoing economic uncertainty.
- Inflation Metrics Analysis: The January Consumer Price Index is projected to rise by 0.29% month-over-month and 2.5% year-over-year, showing improvement but still falling short of the Fed's 2% target, potentially affecting investor rate expectations.
- Market Reaction and Risks: Recent signs of labor market weakness, including an ADP report indicating only 22,000 new private sector jobs, may heighten expectations for further Fed rate cuts, although investors remain optimistic about economic resilience.
- Stock Market Rotation Trend: A significant rotation within the stock market is underway, with the Dow Jones Industrial Average rising over 2% this week, reflecting confidence in economic recovery, despite ongoing weakness in tech stocks.
See More
Becton, Dickinson Q1 Earnings Exceed Expectations
- Earnings Beat: Becton, Dickinson reported a Q1 non-GAAP EPS of $2.91, exceeding expectations by $0.10, reflecting strong performance in the medical device sector and boosting investor confidence.
- Revenue Growth: The company achieved Q1 revenue of $5.25 billion, a 1.5% year-over-year increase, surpassing market expectations by $100 million, indicating stable product demand and solid sales momentum in a competitive market.
- FY26 Guidance Affirmation: Becton, Dickinson affirmed its FY26 revenue growth guidance, projecting GAAP revenue growth in the low single digits, which reflects the company's confidence in future performance while considering corporate overhead migration to Waters Corp.
- Adjusted EPS Outlook: The adjusted diluted EPS guidance is set at $12.35 to $12.65, below the consensus estimate of $14.79, indicating a cautious approach in light of cost control and changing market conditions.
See More
BD Reports Strong Q1 2026 Results and Strategic Milestone
- Strong Performance: BD reported Q1 2026 revenues of $5.252 billion, reflecting a 1.6% year-over-year increase, demonstrating robust growth across key markets and disciplined execution, which positions the company well for future revenue and earnings growth.
- Earnings Growth: The reported diluted earnings per share reached $1.34, up 28.8% from the previous year, indicating successful cost control and operational efficiency, thereby enhancing investor confidence in the company's future performance.
- Strategic Restructuring: BD anticipates completing the merger of its Biosciences and Diagnostic Solutions business with Waters Corporation, marking a significant milestone that will pivot the company towards
See More
U.S. Stock Futures Rise, Focus on Aecom and ON Semiconductor
- Aecom Earnings Forecast: Aecom (NYSE:ACM) is projected to report quarterly earnings of $1.17 per share on revenue of $3.61 billion, indicating stable growth in the infrastructure sector that may enhance investor confidence.
- Stock Performance: Aecom shares rose 2.4% to close at $101.03 on Friday, reflecting optimistic market sentiment ahead of its earnings report, which could attract more investor attention.
- ON Semiconductor Earnings Outlook: Analysts expect ON Semiconductor Corp. (NASDAQ:ON) to post quarterly earnings of 62 cents per share with revenue of $1.54 billion, suggesting ongoing demand and growth potential in the semiconductor market.
- Stock Movement: ON Semiconductor shares gained 0.1% in after-hours trading, closing at $65.23, indicating market anticipation for its earnings report, which may influence future investment decisions.
See More
U.S. Stocks Rally as Dow Hits Record Highs
- Market Sentiment Improvement: The CNN Money Fear & Greed Index rose to 45 on Friday, entering the 'Neutral' zone from a previous reading of 34.2, indicating a significant improvement in market sentiment that could boost investor confidence.
- Dow Jones Surge: The Dow Jones Industrial Average jumped over 1,200 points during Friday's session, closing at 50,115.67 and marking its first breach of the 50,000-point milestone, showcasing a strong market rebound that may attract more capital inflows.
- S&P 500 Strong Performance: The S&P 500 rose by 1.97% to close at 6,932.30, with sectors like industrials, energy, and information technology recording significant gains, reflecting positive signals of economic recovery that could drive corporate earnings growth.
- Consumer Confidence Boost: The University of Michigan's consumer sentiment index increased by 0.9 points to 57.3 in February, surpassing market estimates of 55, indicating enhanced consumer confidence in the economic outlook, which may stimulate consumer spending and economic growth.
See More
Key Focus Areas This Week: Jobs, Consumer Prices, Coca-Cola, CVS, Ford, McDonald's, and More
- Market Performance: The Dow Jones Industrial Average rose by 2.5% and closed above 50,000 for the first time.
- Nasdaq Struggles: In contrast, the Nasdaq Composite ended the week down 1.8%, despite a strong rally on Friday.
See More
U.S. Jobs and Inflation Data Set for Release
- Job Data Expectations: The U.S. is expected to add 60,000 jobs in January, up from 50,000 in December, which could influence the Fed's monetary policy direction amidst ongoing economic uncertainty.
- Inflation Metrics Analysis: The January Consumer Price Index is projected to rise by 0.29% month-over-month and 2.5% year-over-year, showing improvement but still falling short of the Fed's 2% target, potentially affecting investor rate expectations.
- Market Reaction and Risks: Recent signs of labor market weakness, including an ADP report indicating only 22,000 new private sector jobs, may heighten expectations for further Fed rate cuts, although investors remain optimistic about economic resilience.
- Stock Market Rotation Trend: A significant rotation within the stock market is underway, with the Dow Jones Industrial Average rising over 2% this week, reflecting confidence in economic recovery, despite ongoing weakness in tech stocks.
See More
